Triple
T3733476
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | University of Santiago de Compostela |
E79122
|
entity |
| Predicate | hasResearchCenter |
P40
|
FINISHED |
| Object |
CiMUS (Center for Research in Molecular Medicine and Chronic Diseases)
CiMUS (Center for Research in Molecular Medicine and Chronic Diseases) is a biomedical research institute specializing in the study of molecular mechanisms underlying chronic diseases to develop innovative diagnostic and therapeutic strategies.
|
E383567
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CiMUS (Center for Research in Molecular Medicine and Chronic Diseases) | Statement: [University of Santiago de Compostela, hasResearchCenter, CiMUS (Center for Research in Molecular Medicine and Chronic Diseases)]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CiMUS (Center for Research in Molecular Medicine and Chronic Diseases) Context triple: [University of Santiago de Compostela, hasResearchCenter, CiMUS (Center for Research in Molecular Medicine and Chronic Diseases)]
-
A.
Dr. Panjwani Center for Molecular Medicine and Drug Research
Dr. Panjwani Center for Molecular Medicine and Drug Research is a Pakistani research institute focused on advanced studies in molecular medicine, biomedical sciences, and drug discovery.
-
B.
Center for Health and Biosciences
The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
-
C.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
D.
Centre for Cancer Research and Cell Biology
The Centre for Cancer Research and Cell Biology is a major research institute at Queen’s University Belfast dedicated to advancing understanding of cancer biology and developing improved diagnostics and treatments.
-
E.
Immunology Frontier Research Center
The Immunology Frontier Research Center is a leading research institute at Osaka University dedicated to advanced studies in immunology and related biomedical sciences.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: CiMUS (Center for Research in Molecular Medicine and Chronic Diseases) Triple: [University of Santiago de Compostela, hasResearchCenter, CiMUS (Center for Research in Molecular Medicine and Chronic Diseases)]
Generated description
CiMUS (Center for Research in Molecular Medicine and Chronic Diseases) is a biomedical research institute specializing in the study of molecular mechanisms underlying chronic diseases to develop innovative diagnostic and therapeutic strategies.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: CiMUS (Center for Research in Molecular Medicine and Chronic Diseases) Target entity description: CiMUS (Center for Research in Molecular Medicine and Chronic Diseases) is a biomedical research institute specializing in the study of molecular mechanisms underlying chronic diseases to develop innovative diagnostic and therapeutic strategies.
-
A.
Dr. Panjwani Center for Molecular Medicine and Drug Research
Dr. Panjwani Center for Molecular Medicine and Drug Research is a Pakistani research institute focused on advanced studies in molecular medicine, biomedical sciences, and drug discovery.
-
B.
Center for Health and Biosciences
The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
-
C.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
D.
Centre for Cancer Research and Cell Biology
The Centre for Cancer Research and Cell Biology is a major research institute at Queen’s University Belfast dedicated to advancing understanding of cancer biology and developing improved diagnostics and treatments.
-
E.
Immunology Frontier Research Center
The Immunology Frontier Research Center is a leading research institute at Osaka University dedicated to advanced studies in immunology and related biomedical sciences.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ad8b0e4650819090ad7cef094285e8 |
completed | March 8, 2026, 2:43 p.m. |
| NER | Named-entity recognition | batch_69adcb2457f08190a6b94e9895fced2c |
completed | March 8, 2026, 7:16 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b4db192db88190b13e605867a70caf |
completed | March 14, 2026, 3:50 a.m. |
| NEDg | Description generation | batch_69b4dbbc23f08190a03ef4e4197398a4 |
completed | March 14, 2026, 3:53 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69b4dcac6fdc81908998415ffe1aabaa |
completed | March 14, 2026, 3:57 a.m. |
Created at: March 8, 2026, 3:34 p.m.